GSK has received Canadian approval for its respiratory syncytial virus vaccine in adults between 50 and 59, the company said ...

In October, the Centers for Disease Control and Prevention recommended that high-risk adults get a second updated Covid ...

A fresh wave of disinformation about vaccines is flaring amid the 2024 campaign. The FDA's top vaccine official believes ...

Over the past year, you may have heard about an experimental vaccine for pancreatic cancer. The news is good: The ...

Pediatricians are stunned by the possibility that vaccines proven to save kids’ lives could be banned under a second Trump ...

Studies have shown that people living with HIV are more vulnerable to severe cases of mpox. However, even with heightened risk, they face difficulties accessing the vaccine. Many HIV-positive ...

Ongoing staff recruitment challenges, along with persistent vaccine reluctance, are the reasons why only 11% of Florida’s ...

Despite the performance, the company expects to be at the lower end of its revenue guidance window for the year of between €2 ...

Medidata has debuted two new bundled services meant to speed up and support clinical trials in oncology and vaccines, the ...

Aid agencies said that children in some areas of northern Gaza where Israel is mounting an offensive against Hamas will miss ...

Policy, funding, and public apathy hold back the search for more advanced COVID vaccines — but researchers persist and have ...

Recent comments from both JD Vance and Robert F. Kennedy Jr. could signal how a Trump administration erodes public confidence ...